Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Evotec has partnered Bristol-Myers Squibb to launch another Bridge programme, this time focusing on the universities of Birmingham, Dundee, Edinburgh and Nottingham.

Evotec has partnered Bristol-Myers Squibb to launch another Bridge programme, this time focusing on the universities of Birmingham, Dundee, Edinburgh and Nottingham.

Opioid addiction care provider Groups Recover Together and healthcare management platform developer Vim each raised $60m, with Optum Ventures backing both rounds.

Ericsson and Maersk Growth were among the investors in the autonomous logistics vehicle developer's series B round.

The Chernin Group led the health tracker producer's series C round, which also featured Square and Eisai, at an $800m valuation.

SoftBank Vision Fund led a $75m round valuing OKR platform developer WorkBoard at $800m while therapist network provider Headway hit a $750m valuation.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

NeoGenomics has agreed to buy portfolio company Inivata, a liquid biopsy platform developer, a year after it invested $25m.

Mogrify has collected $17m in a second series A tranche led by Parkwalk Advisors to bring the round’s total to $33m.